1. An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)

    An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)

    Dan Loeb thinks Amgen could be worth $249 per share, or 80% more than current levels.  In his latest filing with the SEC, Loeb's Third Point was shown to be holding 450,000 shares of the company...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors